EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C20H28O2 |
| Net Charge | 0 |
| Average Mass | 300.442 |
| Monoisotopic Mass | 300.20893 |
| SMILES | CC1=C(/C=C/C(C)=C/C=C/C(C)=C/CO)C(C)(C)CCC1=O |
| InChI | InChI=1S/C20H28O2/c1-15(7-6-8-16(2)12-14-21)9-10-18-17(3)19(22)11-13-20(18,4)5/h6-10,12,21H,11,13-14H2,1-5H3/b8-6+,10-9+,15-7+,16-12+ |
| InChIKey | PLIUCYCUYQIBDZ-RMWYGNQTSA-N |
| Roles Classification |
|---|
| Application: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| all-trans-4-oxoretinol (CHEBI:44597) has functional parent all-trans-retinol (CHEBI:17336) |
| all-trans-4-oxoretinol (CHEBI:44597) has role antineoplastic agent (CHEBI:35610) |
| all-trans-4-oxoretinol (CHEBI:44597) is a cyclic ketone (CHEBI:3992) |
| all-trans-4-oxoretinol (CHEBI:44597) is a enone (CHEBI:51689) |
| all-trans-4-oxoretinol (CHEBI:44597) is a primary allylic alcohol (CHEBI:134394) |
| all-trans-4-oxoretinol (CHEBI:44597) is a retinoid (CHEBI:26537) |
| IUPAC Name |
|---|
| 4-oxoretinol |
| Synonyms | Source |
|---|---|
| 4-ketoretinol | ChemIDplus |
| 4-oxoretinol | ChemIDplus |
| all-trans-4-oxoretinol | ChEBI |
| 4-oxo-ROL | ChEBI |
| UniProt Name | Source |
|---|---|
| all-trans-4-oxoretinol | UniProt |
| Manual Xrefs | Databases |
|---|---|
| OXR | PDBeChem |
| C16683 | KEGG COMPOUND |
| HMDB0012329 | HMDB |
| DB02699 | DrugBank |
| US6150421 | Patent |
| Registry Numbers | Sources |
|---|---|
| Reaxys:14831438 | Reaxys |
| CAS:62702-55-0 | KEGG COMPOUND |
| CAS:62702-55-0 | ChemIDplus |
| Citations |
|---|